Research оn healthcare oxygen measures during the COVID-19 pandemic: latest trends and current priorities

О. П. Баула, О. О. Салій, А. Г. Галстян, Т. В. Пазерська
{"title":"Research оn healthcare oxygen measures during the COVID-19 pandemic: latest trends and current priorities","authors":"О. П. Баула, О. О. Салій, А. Г. Галстян, Т. В. Пазерська","doi":"10.32352/0367-3057.6.22.02","DOIUrl":null,"url":null,"abstract":"Medical oxygen is a critically needed medicine in the treatment of coronavirus disease. During out breaks of the COVID-19 pandemic, the needs of health care institutions for medical oxygen increase by 5-6 times. The issue of the reliable functioning of the oxygen supply system of health care institutions during the COVID-19 pandemic is extremely urgent and requires systematic research. \nThe purpose of the work was to conduct research on measures to provide oxygen to health care facilities during the COVID-19 pandemic, to establish risk factors in its production and supply, and to determine priority directions for guaranteeing the ability to provide medical assistance in the treatment of coronavirus disease. \nThe methods of systematic approach, bibliographic, information search, marketing analysis, as well as generalization and analysis were used during the research. \nThe study showed that medical use of oxygen as a medicine, oxygen produced by medical devices, and technical oxygen was allowed at the state level. Domestic manufacturers produce medical oxygen that meets all regulatory requirements for medicinal products. In Ukraine, 36 drugs based on medical oxygen are registered, the production of which is carried out by 26 enterprises that have licenses for the production of medicinal products. During the pandemic, it was allowed for medical use of technical oxygen, which should meet the quality indicators of medical oxygen. The use of oxygen, which is produced by medical devices, which include oxygen generators and oxygen concentrators, which must meet the requirements of the Technical Regulations, became a significant measure for the expansion of oxygen therapy. \nDuring the implementation of all measures to provide oxygen, there are risks of a national and branch nature, as well as specific risks associated with the characteristics of different types of oxygen (oxygen as a medicine, oxygen produced by medical devices, technical oxygen). The identified list of risks and their analysis in the provision of oxygen to health care facilities during the COVID-19 pandemic will provide an opportunity to develop the concept of general risk assessment and risk management processes to guarantee the ability to provide adequate medical care in the treatment of coronavirus disease.","PeriodicalId":32942,"journal":{"name":"Farmatsevtichnii zhurnal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmatsevtichnii zhurnal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32352/0367-3057.6.22.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Medical oxygen is a critically needed medicine in the treatment of coronavirus disease. During out breaks of the COVID-19 pandemic, the needs of health care institutions for medical oxygen increase by 5-6 times. The issue of the reliable functioning of the oxygen supply system of health care institutions during the COVID-19 pandemic is extremely urgent and requires systematic research. The purpose of the work was to conduct research on measures to provide oxygen to health care facilities during the COVID-19 pandemic, to establish risk factors in its production and supply, and to determine priority directions for guaranteeing the ability to provide medical assistance in the treatment of coronavirus disease. The methods of systematic approach, bibliographic, information search, marketing analysis, as well as generalization and analysis were used during the research. The study showed that medical use of oxygen as a medicine, oxygen produced by medical devices, and technical oxygen was allowed at the state level. Domestic manufacturers produce medical oxygen that meets all regulatory requirements for medicinal products. In Ukraine, 36 drugs based on medical oxygen are registered, the production of which is carried out by 26 enterprises that have licenses for the production of medicinal products. During the pandemic, it was allowed for medical use of technical oxygen, which should meet the quality indicators of medical oxygen. The use of oxygen, which is produced by medical devices, which include oxygen generators and oxygen concentrators, which must meet the requirements of the Technical Regulations, became a significant measure for the expansion of oxygen therapy. During the implementation of all measures to provide oxygen, there are risks of a national and branch nature, as well as specific risks associated with the characteristics of different types of oxygen (oxygen as a medicine, oxygen produced by medical devices, technical oxygen). The identified list of risks and their analysis in the provision of oxygen to health care facilities during the COVID-19 pandemic will provide an opportunity to develop the concept of general risk assessment and risk management processes to guarantee the ability to provide adequate medical care in the treatment of coronavirus disease.
新冠肺炎大流行期间的医疗氧气措施研究:最新趋势和当前优先事项
医用氧气是治疗冠状病毒疾病急需的药物。在新冠肺炎疫情爆发期间,医疗机构对医用氧气的需求增加了5-6倍。新冠肺炎大流行期间医疗保健机构氧气供应系统的可靠运行问题极为紧迫,需要进行系统研究。这项工作的目的是研究在新冠肺炎大流行期间向卫生保健设施提供氧气的措施,确定其生产和供应中的风险因素,并确定确保在冠状病毒疾病治疗中提供医疗援助的能力的优先方向。研究采用了系统方法、文献资料法、信息检索法、市场分析法以及归纳分析法。研究表明,国家允许将氧气用作药物、医疗器械生产的氧气和技术氧气的医疗用途。国内制造商生产的医用氧气符合药品的所有监管要求。在乌克兰,注册了36种以医用氧气为基础的药物,由26家拥有药品生产许可证的企业进行生产。在疫情期间,它被允许用于医用技术氧气,应符合医用氧气的质量指标。使用由医疗设备生产的氧气,包括氧气发生器和氧气浓缩器,必须符合《技术条例》的要求,成为扩大氧气治疗的一项重要措施。在实施所有提供氧气的措施期间,存在国家和分支性质的风险,以及与不同类型氧气的特性相关的特定风险(作为药物的氧气、医疗器械生产的氧气、技术氧气)。在新冠肺炎大流行期间,在向卫生保健设施提供氧气方面确定的风险清单及其分析将为发展一般风险评估和风险管理流程的概念提供机会,以确保在治疗冠状病毒疾病时提供足够医疗护理的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
43
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书